The content on this site is intended for healthcare professionals only

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

2018 ASCO Annual Meeting

1 - 5 Jun 2018

McCormick Place, Chicago, United States of America

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies

ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )

Repurposing selective PDE5 inhibitors as anti-cancer agents

Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium

Repurposing selective PDE5 inhibitors as anti-cancer agents ( Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium )

First results of DREAM trial of frontline durvalumab for mesothelioma

Prof Anna Nowak - The University of Western Australia, Perth, Australia

First results of DREAM trial of frontline durvalumab for mesothelioma ( Prof Anna Nowak - The University of Western Australia, Perth, Australia )

Results from the phase I ICONIC trial

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )

Chemotherapy plus durvalumab in triple negative breast cancer

Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany

Chemotherapy plus durvalumab in triple negative breast cancer ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )

Phase II results of olaparib and abiraterone for mCRPC

Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK

Phase II results of olaparib and abiraterone for mCRPC ( Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK )

Global treatment pattern variations in HCC

Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico

Global treatment pattern variations in HCC ( Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico )

Design and interim safety analysis of GeparX trial

Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany

Design and interim safety analysis of GeparX trial ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )

Key developments in non-metastatic and metastatic hormone-sensitive prostate can...

Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria De...

Key developments in non-metastatic and metastatic hormone-sensitive prostate cancer ( Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria De Santis )

International cancer control plans

Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana

International cancer control plans ( Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana )

Economic impact of NGS in non small cell lung cancer

Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA

Economic impact of NGS in non small cell lung cancer ( Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA )

Subcutaneous daratumumab shows benefit in patients with relapsed or refractory m...

Dr Ajai Chari - Mount Sinai Hospital, New York, USA

$Subcutaneous daratumumab shows benefit in patients with relapsed or refractory multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )$

Avelumab in combinations for lung cancer and update from ALEX study

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA

Avelumab in combinations for lung cancer and update from ALEX study ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )

Updates in melanoma from ASCO 2018

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands

Updates in melanoma from ASCO 2018 ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )

Novel fusion proteins to target PD-L1 in HPV associated cancers

Dr James Gulley - Center for Cancer Research, Washington, USA

Novel fusion proteins to target PD-L1 in HPV associated cancers ( Dr James Gulley - Center for Cancer Research, Washington, USA )

Daratumumab in combination with carfilzomib and dexamethasone for relapsed multi...

Dr Ajai Chari - Mount Sinai Hospital, New York, USA

Daratumumab in combination with carfilzomib and dexamethasone for relapsed multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )

Phase I study results of M7824 for patients with HPV associated cancers

Dr Julius Strauss - Center for Cancer Research, Washington, USA

Phase I study results of M7824 for patients with HPV associated cancers ( Dr Julius Strauss - Center for Cancer Research, Washington, USA )

Phase III results of PROSPECT study for metastatic, castration-resistant prostat...

Dr James Gulley - Center for Cancer Research, Washington, USA

Phase III results of PROSPECT study for metastatic, castration-resistant prostate cancer ( Dr James Gulley - Center for Cancer Research, Washington, USA )

Pancreatic survival improved with trial chemotherapy regimen after surgery

Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France

Pancreatic survival improved with trial chemotherapy regimen after surgery ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )

Aspirin combined with acid-reducing medicine offers moderate benefits in patient...

Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic o...

Aspirin combined with acid-reducing medicine offers moderate benefits in patients with Barrett’s oesophagus ( Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic of Ireland )

Pre-operative chemotherapy with radiation may help people with pancreatic cancer...

Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands

Pre-operative chemotherapy with radiation may help people with pancreatic cancer live longer ( Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands )

Heated abdominal chemotherapy not beneficial in patients with advanced colorecta...

Dr Francois Quenet - Regional Cancer Institute, Montpellier, France

Heated abdominal chemotherapy not beneficial in patients with advanced colorectal cancer ( Dr Francois Quenet - Regional Cancer Institute, Montpellier, France )

Comment: Pancreatic cancer survival extended by over a year with chemotherapy re...

Dr Andrew Epstein and Prof Richard Schilsky

Comment: Pancreatic cancer survival extended by over a year with chemotherapy regimen ( Dr Andrew Epstein and Prof Richard Schilsky )

Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cance...

Dr Andrew Epstein and Prof Richard Schilsky

Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high risk individuals ( Dr Andrew Epstein and Prof Richard Schilsky )

Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemo...

Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven

Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation ( Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven )

Comment: No benefit of heated abdominal chemotherapy in advanced colorectal canc...

Prof Richard Schilsky, Dr Andrew Epstein and Dr Francois Quenet

Comment: No benefit of heated abdominal chemotherapy in advanced colorectal cancer ( Prof Richard Schilsky, Dr Andrew Epstein and Dr Francois Quenet )

Pancreatic cancer survival extended by over a year with chemotherapy regimen

Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France

Pancreatic cancer survival extended by over a year with chemotherapy regimen ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )

Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high...

Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic o...

Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high risk individuals ( Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic of Ireland )

Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation

Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands

Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation ( Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands )

No benefit of heated abdominal chemotherapy in advanced colorectal cancer

Dr Francois Quenet - Regional Cancer Institute, Montpellier, France

No benefit of heated abdominal chemotherapy in advanced colorectal cancer ( Dr Francois Quenet - Regional Cancer Institute, Montpellier, France )

Dabrafenib halts growth of low-grade paediatric glioma

Dr Mark Kieran - Dana Farber Cancer Institue, Boston, USA

Dabrafenib halts growth of low-grade paediatric glioma ( Dr Mark Kieran - Dana Farber Cancer Institue, Boston, USA )

ASCO 2018: Novel treatment strategies in prostate cancer therapeutics

Prof Karim Fizazi and Dr Neal Shore

ASCO 2018: Novel treatment strategies in prostate cancer therapeutics ( Prof Karim Fizazi and Dr Neal Shore )

ASCO 2018: Latest developments in non-metastatic and metastatic castration-resis...

Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik

ASCO 2018: Latest developments in non-metastatic and metastatic castration-resistant prostate cancer ( Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik )

Finding appropriate doses for HER2 positive breast cancers

Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA

Finding appropriate doses for HER2 positive breast cancers ( Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA )

Updates in targeted therapy for melanoma

Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany

Updates in targeted therapy for melanoma ( Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany )

Education, collaboration and communication in global cancer control

Dr Susannah Stanway - Royal Marsden NHS Foundation Trust, London, UK

Education, collaboration and communication in global cancer control ( Dr Susannah Stanway - Royal Marsden NHS Foundation Trust, London, UK )

Health related quality of life findings from COMBI-AD

Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany

Health related quality of life findings from COMBI-AD ( Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany )

Developing a survivin vaccine for glioblastoma

Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA

Developing a survivin vaccine for glioblastoma ( Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA )

Early results from a 3rd gen EGFR-TKI in advanced NSCLC

Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea

Early results from a 3rd gen EGFR-TKI in advanced NSCLC ( Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea )

New pathways in pancreatic cancer

Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA

New pathways in pancreatic cancer ( Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA )

OPTIMISMM trial for refractory multiple myeloma

Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA

$OPTIMISMM trial for refractory multiple myeloma ( Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA )$

Treatment updates in Merkel cell carcinoma

Dr Paul Nghiem - University of Washington, Seattle, USA

Treatment updates in Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )

Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast ...

Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany

Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast cancer ( Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany )

New treatment markers for myeloma

Dr Jesus San Miguel - Universidad de Navarra, Pamplona, Spain

New treatment markers for myeloma ( Dr Jesus San Miguel - Universidad de Navarra, Pamplona, Spain )

Most breast cancer patients could avoid chemo with use of genetic testing

Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA

Most breast cancer patients could avoid chemo with use of genetic testing ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )

Pembrolizumab works better than chemotherapy alone as initial treatment for NSCL...

Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA

Pembrolizumab works better than chemotherapy alone as initial treatment for NSCLC ( Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA )

Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma

Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy

Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma ( Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy )

Sunitinib with or without surgery for metastatic renal cell carcinoma

Prof Arnaud Mejean - Paris Descartes University, Paris, France

Sunitinib with or without surgery for metastatic renal cell carcinoma ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )

Comment: Genetic testing of early breast tumours could allow patients to go with...

Dr Harold Burstein & Prof Richard Schilsky

Comment: Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Harold Burstein & Prof Richard Schilsky )

Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer tr...

Dr John Heymach & Prof Richard Schilsky

Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer treatment ( Dr John Heymach & Prof Richard Schilsky )

Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemothe...

Prof Richard Schilsky & Dr Gianni Bisogno

Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy ( Prof Richard Schilsky & Dr Gianni Bisogno )

Comment: Kidney surgery may be unneeded in many intermediate-risk patients

Dr Sumanta Pal & Prof Richard Schilsky

Comment: Kidney surgery may be unneeded in many intermediate-risk patients ( Dr Sumanta Pal & Prof Richard Schilsky )

Genetic testing of early breast tumours could allow patients to go without chemo

Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA

Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )

PD-1 immunotherapy better than chemo alone as first line lung cancer treatment

Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil

PD-1 immunotherapy better than chemo alone as first line lung cancer treatment ( Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil )

Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy

Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy

Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy ( Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy )

Kidney surgery may be unneeded in many intermediate-risk patients

Prof Arnaud Mejean - Paris Descartes University, Paris, France

Kidney surgery may be unneeded in many intermediate-risk patients ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )

ASCO 2018: Latest in bladder cancer treatments

Prof Thomas Powles & Prof Shahrokh Shariat

ASCO 2018: Latest in bladder cancer treatments ( Prof Thomas Powles & Prof Shahrokh Shariat )

Cancer treatment in the last 6 months of life: when inaction can outperform acti...

Dr Bishal Gyawali - Brigham and Women's Hospital, Boston, USA

Cancer treatment in the last 6 months of life: when inaction can outperform action ( Dr Bishal Gyawali - Brigham and Women's Hospital, Boston, USA )

ASCO 2018: Integrating genomic data throughout treatment for prostate cancer

Prof Kurt Miller and Prof Bertrand Tombal

ASCO 2018: Integrating genomic data throughout treatment for prostate cancer ( Prof Kurt Miller and Prof Bertrand Tombal )

A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER...

Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA

A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers ( Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA )

Zoptarelin no better than doxarubicin for second-line advanced endometrial cance...

Dr David Miller - The University of Texas Southwestern Medical Center

Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer ( Dr David Miller - The University of Texas Southwestern Medical Center )

Improving global breast cancer care

Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul, Braz...

Improving global breast cancer care ( Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul, Brazil )

What will we expect from novel therapies for oesophageal and gastric malignancie...

Prof Ramon De Mello - University of Algarve, Faro, Portugal

What will we expect from novel therapies for oesophageal and gastric malignancies? ( Prof Ramon De Mello - University of Algarve, Faro, Portugal )

Nelarabine in newly diagnosed paediatric T-cell malignancies

Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA

Nelarabine in newly diagnosed paediatric T-cell malignancies ( Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA )

Immunotherapy trials and hyperprogressive disease

Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain

Immunotherapy trials and hyperprogressive disease ( Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )

First-in-human phase 1 study of TAK-931 for solid tumours

Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan

First-in-human phase 1 study of TAK-931 for solid tumours ( Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan )

Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in...

Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France

Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in lung cancer patients ( Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France )

The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CL...

Prof William Wierda - MD Anderson Cancer Center, Houston, USA

The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients ( Prof William Wierda - MD Anderson Cancer Center, Houston, USA )

Development of blood tests for early lung cancer

Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA

Development of blood tests for early lung cancer ( Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA )

Linking Lynch Syndrome and microsatellite instability in tumours

Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA

Linking Lynch Syndrome and microsatellite instability in tumours ( Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA )

Matching personalised therapies to patients in the IMPACT trial

Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA

Matching personalised therapies to patients in the IMPACT trial ( Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA )

Atezolizumab with chemotherapy improves PFS in squamous NSCLC

Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA

Atezolizumab with chemotherapy improves PFS in squamous NSCLC ( Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA )

Matching mutations in tumours to precision medicine improves survival

Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA

Matching mutations in tumours to precision medicine improves survival ( Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA )

Development of blood tests for early lung cancer

Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA

Development of blood tests for early lung cancer ( Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA )

Genomic study links several new cancers to Lynch Syndrome

Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA

Genomic study links several new cancers to Lynch Syndrome ( Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA )

Taselisib with fulvestrant slows growth of advanced breast cancer

Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA

Taselisib with fulvestrant slows growth of advanced breast cancer ( Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )

Atezolizumab with chemotherapy improves PFS in squamous NSCLC

Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA

Atezolizumab with chemotherapy improves PFS in squamous NSCLC ( Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA )

More from ecancer